Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
09/2005
09/28/2005CN1673214A Imine analogs of meglumine iothalamate compounds and their synthesis process
09/27/2005US6949667 A cyclic phosphonic acid ester derivatives for use as chemical intermediates for the production of physiologically active drugs or agricultural chemicals
09/27/2005US6949660 Chiral (1pyrrolino) fullerene derivatives
09/27/2005US6949639 lanthanide(III) chelates
09/27/2005US6949635 use with DNA polymerases that are thermostable or which contain an altered dNMP binding site
09/27/2005US6949621 Polycondensation with dehalogenation 2,7-dihalo-9-oxo-9-phosphafluorene, reacting with arylenebisboronic acid and polycondensation, or polycondensation with an olefin; luminescent or electrochromic
09/27/2005CA2275866C Process for making glyphosate by oxidizing n-substituted glyphosates
09/22/2005WO2005087710A1 Aminophenylpropanoic acid derivative
09/22/2005WO2005087697A1 METAL COMPLEX COMPRISING β-DIKETONATO AS LIGAND
09/22/2005WO2005087370A1 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005086961A2 Improved preparation of halohydroccarbyl phosphonic acid diestres
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005US20050209455 Bisphosphines as bidentate ligands
09/22/2005US20050209320 Compounds comprise an androgen receptor (AR) binding moiety which selectively targets the compounds to AR-expressing cancer cells, and a cytotoxic alkylating moiety, such as a nitrogen mustard moiety; (2R)-2-hydroxy-3-[(4-hydroxyphenyl)thio]-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
09/22/2005US20050209253 Corticotropin releasing factor (CRF) receptor antagonists; nervous system disorders, ischemia, gastrointestinal disorders, hypertension, eating disorders, sleep disorders; e.g. 2-(1-[7-(2,6-dibromo-4-trifluoromethyl-phenyl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-piperidin-2-yl)-ethanol
09/22/2005US20050209246 Prodrugs of piperazine and substituted piperidine antiviral agents
09/22/2005US20050209212 2-(2-(3-carboxyphenylcarbamoyl)pyrrolidin-4-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapenem-3-carboxylic acid; carbapenems derivatives containing a carboxy substituted phenyl group; broad spectrum antibacterial activity; good stability; beta-lactamases inhibitors; improvement over imipenem
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050209105 Preparation of solid ammonium glyphosate using organic solvent in extraction
09/22/2005US20050208124 Drugs containing riboflavin-type compounds
09/22/2005DE102004010662A1 Verfahren zur Herstellung von Verbindungen mit quaternären sp2-hybridisierten Stickstoffatomen A process for the preparation of compounds with quaternary sp 2 -hybridized nitrogen atoms
09/22/2005CA2560111A1 Aminophenylpropanoic acid derivative
09/22/2005CA2559086A1 C1-symmetric bisphosphine ligands and their use in the asymmetric synthesis of pregabalin
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1576655A2 Stabilized semiconductor nanocrystals
09/21/2005EP1575972A1 Nucleic acid labeling compounds
09/21/2005EP1575966A1 Therapeutic quinazoline derivatives
09/21/2005EP1575965A1 Process for the preparation of phosphitylation agents
09/21/2005EP1575964A2 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists
09/21/2005EP1575946A1 Quinazoline compounds
09/21/2005EP1575705A2 Process for the recovery of phosphorus and iodine containing catalyst components
09/21/2005EP1575591A1 Heterocycles and uses thereof
09/21/2005EP1575486A2 Method and compositions for identifying anti-hiv therapeutic compounds
09/21/2005EP1296634B1 Dental material containing phosphonic acids
09/21/2005EP1151034B1 Phosphite additives in polyolefins
09/21/2005CN1671643A Bipolar trans carotenoid salts and their uses
09/21/2005CN1671395A Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
09/21/2005CN1670025A Process for preparing amorphous adefovir dipivoxil
09/21/2005CN1670024A Acyclic nucleoside phosphonate derivatives
09/21/2005CN1670023A Process for preparing phytic acid by ion-exchange method
09/20/2005US6946578 Process for producing phenoxyphosphazene compound, flame-retardant resin composition, and flame-retardant resin molding
09/20/2005US6946569 high stereoselectivity; mannitol and tartaric acid starting materials, hydrogenation of ketones, imines, and olefins; 1,2((2,2',5,5'-tetramethyl, 3,3',4,4'-tetrahydroxy) bisphospholane)benzene.
09/20/2005US6946568 Titanium, zirconium, hafnium, vandium, niobium or tantalum complexed with an imine and an amine, oxy or sulfide
09/20/2005US6946560 Ligands for metals and improved metal-catalyzed processes based thereon
09/20/2005US6946471 2-(2,6-Dichlorophenyl)-Diarylimidazoles
09/20/2005US6946460 such as cis-4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]-N-methyl-N-(3-phenyl-2(E)-propenyl)-benzenemethanamine;
09/20/2005US6946115 Especially substituted cyclic 1,3- propanyl phosphate, phosphonate and phosphoramidate esters.
09/20/2005US6946005 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibers
09/20/2005CA2401248C Method for the production of n-(phosphonomethyl)glycine
09/20/2005CA2376853C Poly(phosphonoarylacetylene) and chiral sensor comprising the same
09/20/2005CA2226111C In situ preparation of nucleoside phosphoramidites and their use in synthesis of oligonucleotides
09/20/2005CA2127047C Preparation of astaxanthin, novel intermediates therefor and the preparation thereof
09/15/2005WO2005085262A1 Process for producing aminophosphonic acid derivative
09/15/2005WO2005085207A2 Method for the production of ionic fluids the cation of which comprises a quaternary sp2 - hybridised nitrogen atom
09/15/2005WO2005084307A2 Use of lipid conjugates in the treatment of disease
09/15/2005WO2005056812A3 Practical, cost-effective synthesis of ubiquinones
09/15/2005WO2005032494A3 Lpa receptor agonists and antagonists and methods of use
09/15/2005WO2004112704A3 Substituted piperidine compounds and methods of their use
09/15/2005US20050203314 Method for generating secondary phosphines
09/15/2005US20050203306 Preparation of halohydrocarbyl phosphonic acid diesters
09/15/2005US20050203289 Functional biopolymer modification reagents and uses thereof
09/15/2005US20050203183 Chemical intermediates to statins and synthesis thereof; for example, reacting triethylphosphite with (6-acetoxymethyl-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid, tert-butyl ester to form (6-(diethoxyphosphorylmethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid, tert-butyl ester
09/15/2005US20050203041 Antisense compound and method for selectively killing activated T cells
09/15/2005US20050202507 Diazaphosphacycles
09/15/2005US20050202171 Precursor compounds for deposition of ceramic and metal films and preparation methods thereof
09/15/2005US20050201933 Macrocyclic chelants for metallopharmaceuticals
09/15/2005DE102004008784B3 Verfahren zur Durchkontaktierung von Feldeffekttransistoren mit einer selbstorganisierten Monolage einer organischen Verbindung als Gatedielektrikum A method for through-contacting of field effect transistors with a self-assembled monolayer of an organic compound as the gate dielectric
09/15/2005CA2558416A1 Use of lipid conjugates in the treatment of disease
09/14/2005EP1574216A1 Inhibitors of phosphatidyl Myo-Inositol Cycle
09/14/2005EP1572704A1 Phosphorus-containing piperazine derivatives as ccr1 antagonists
09/14/2005EP1572703A2 Process for the preparation of a melamine based flame retardant and polymer composition
09/14/2005EP1572645A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
09/14/2005EP1572621A1 Cyclohexane derivatives and methods for their preparation
09/14/2005EP1572360A1 Monocyclopentadienyl complexes
09/14/2005EP1572359A1 Monocyclopentadienyl complexes
09/14/2005EP1499609A4 Pesticidal heterocycles
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005CN1669165A Supporting electrolyte for cell and method for production thereof, and cell
09/14/2005CN1668625A Epoxy-stabilized polyphosphate compositions
09/14/2005CN1668608A Heterodiamondoids
09/14/2005CN1668601A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors
09/14/2005CN1668287A Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
09/14/2005CN1218919C Fluorene derivatives and their application
09/14/2005CN1218705C Anti SARS virus medicine and synthesizing method thereof
09/13/2005US6943267 compounds structurally resemble the substrates of the enzymes, but have nonhydrolyzable mono protonated thiophosphonate salts; chromatography or distillations not required
09/13/2005US6943250 Protected aminofunctionalized polymerization initiators and methods of making and using same
09/13/2005US6943226 Metallocenes having two or more different active sites, one of which is coordinated to an unsaturated nitrogenous ligand, e.g., an imine; polymer control; uniformity; highly active; linear low density polyethylene; isotactic polypropylene
09/13/2005US6943194 oxidizing 3-(tert-butyl dimethylsilyl)oxy-4-methoxybenzaldehyde with potassium permanganate to form carboxylic acid, converting to corresponding acid chloride, protecting with a butyllithium derivative, deprotecting to form phenstatin
09/13/2005US6943191 dihydroxy or diketoaromatic compounds; protein kinase inhibitors; antiproliferative activity
09/13/2005US6943163 7-Alkyl and cycloalkyl-substituted imidazotriazinones
09/09/2005WO2005083101A1 Process for producing phospholipid containing long chain polyunsaturated fatty acid as constituent thereof and utilization of the same
09/09/2005WO2005082917A1 4-phosphorylpyrazole derivatives for pesticidal use
09/09/2005WO2005082916A1 5-phosphorylaminopyrazole derivatives and their use as pesticides
09/09/2005WO2005082915A1 Amorphous forms of risedronate monosodium
09/09/2005WO2005082914A2 Modulators of lysophosphatidic acid (lpa) signaling
09/09/2005WO2005082864A1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors
09/09/2005WO2005082830A1 Process for the carbonylation of ethylenically or acetylenically unsaturated compounds
09/09/2005WO2005082531A1 Transition metal complexes and their uses as catalysts
09/09/2005WO2005047299A3 Chiral di- and triphosphites
1 ... 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 ... 554